Abbott initiates new clinical trial to improve outcomes in patients with advanced heart failure

The first-of-its-kind team-hf study seeks to improve clinical outcomes in patients with worsening heart failure trial establishes new, objective criteria to identify patients most at risk for developing end-stage heart failure and potentially offer life-saving therapeutic options sooner in their disease progression abbott park, ill., oct. 24, 2024 /prnewswire/ -- abbott (nyse: abt) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy options.
ABT Ratings Summary
ABT Quant Ranking